Publications by authors named "K Techatraisak"
The Thai Menopause Society is an academic organization consisting of healthcare professionals engaged in menopause medicine. The position statement was first issued in 1994 and updated in 2003 and 2023. Herein, we reviewed the important updates of the 2023 position statement on menopausal hormone therapy (MHT) as an international reference for healthcare professionals in Thailand.
View Article and Find Full Text PDFObjective: To determine the quality of life (QoL) in Thai women with various types of abnormal uterine bleeding (AUB).
Methods: A cross-sectional study was conducted on 353 AUB patients between November 2010 and January 2012. They were grouped according to the duration of symptom: <6 months (acute AUB, n = 122), ≥6 months (chronic AUB, n = 138), and postmenopausal bleeding (PMB, n = 93); and the bleeding pattern: hypermenorrhea (n = 24) and irregular bleeding (n = 236).
Article Synopsis
- A study in six Asian countries evaluated the real-world impact of dienogest treatment on health-related quality of life (HRQoL) in women with endometriosis, enrolling 887 participants with endometriosis-associated pelvic pain (EAPP).
- Results indicated significant improvements in HRQoL scores, especially in pain levels and feelings of control, with the most significant changes observed at 6 and 24 months after starting treatment.
- While many patients and doctors expressed satisfaction with dienogest, common side effects included bleeding irregularities and amenorrhea, with nearly 40% experiencing treatment-emergent adverse events.
The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial.
Sci Rep
January 2022
Women with chronic abnormal uterine bleeding-ovulatory dysfunction (AUB-O) are at increased risk of endometrial neoplasia. We conducted a non-inferiority randomized controlled trial to determine the effectiveness of two cyclic-progestin regimens orally administered 10 d/month for 6 months on endometrial protection and menstruation normalization in women with AUB-O. There were 104 premenopausal women with AUB-O randomized to desogestrel (DSG 150 µg/d, n = 50) or medroxyprogesterone acetate (MPA 10 mg/d, n = 54) group.
View Article and Find Full Text PDFObjective: This study aimed to investigate the relationship between menopausal hormone therapy (MHT) and endometriosis recurrence in women who underwent hysterectomy with bilateral salpingo-oophorectomy to treat endometriosis.
Method: This retrospective cohort study included 330 women who underwent definitive surgery to treat endometriosis during 1996-2012. Follow-up data until December 2018 were analyzed.